AstraZeneca Announces Discontinuation of STABILIZE-CKD and DIALIZE-Outcomes Phase III Trials

AstraZeneca Announces Discontinuation of STABILIZE-CKD and DIALIZE-Outcomes Phase III Trials

December 1, 2023: AstraZeneca announced that it has decided to discontinue the STABILIZE-CKD trial and the DIALIZE-Outcomes Phase III trial that evaluate zirconium cyclosilicate sodium hydrate (product name: Lokelma) due to delays in patient enrollment and low event rates. The two studies were designed to evaluate the effects of the drug on the cardiac and renal systems.

Both studies were part of the CRYSTALIZE evidence program that evaluates the potential benefits of L...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.